Efficacy and limitations of senolysis in atherosclerosis
Open accessThe DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Aims: Traditional markers of cell senescence including p16, Lamin B1, and senescence-associated beta galactosidase (SAβG) suggest very high frequencies of senescent cells in atherosclerosis, while their removal via ‘senolysis’ has been reported to reduce atherogenesis. However, selective killing of a variety of different cell types can exacerbate atherosclerosis. We therefore examined the specificity of senescence markers in vascular smooth muscle cells (VSMCs) and the effects of genetic or pharmacological senolysis in atherosclerosis. Methods and results: We examined traditional senescence markers in human and mouse VSMCs in vitro, and in mouse atherosclerosis. p16 and SAβG increased and Lamin B1 decreased in replicative senescence and stress-induced premature senescence (SIPS) of cultured human VSMCs. In contrast, mouse VSMCs undergoing SIPS showed only modest p16 up-regulation, and proliferating mouse monocyte/macrophages also expressed p16 and SAβG. Single cell RNA-sequencing (scRNA-seq) of lineage-traced mice showed increased p16 expression in VSMC-derived cells in plaques vs. normal arteries, but p16 localized to Stem cell antigen-1 (Sca1)+ or macrophage-like populations. Activation of a p16-driven suicide gene to remove p16+ vessel wall- and/or bone marrow-derived cells increased apoptotic cells, but also induced inflammation and did not change plaque size or composition. In contrast, the senolytic ABT-263 selectively reduced senescent VSMCs in culture, and markedly reduced atherogenesis. However, ABT-263 did not reduce senescence markers in vivo, and significantly reduced monocyte and platelet counts and interleukin 6 as a marker of systemic inflammation. Conclusions: We show that genetic and pharmacological senolysis have variable effects on atherosclerosis, and may promote inflammation and non-specific effects respectively. In addition, traditional markers of cell senescence such as p16 have significant limitations to identify and remove senescent cells in atherosclerosis, suggesting that senescence studies in atherosclerosis and new senolytic drugs require more specific and lineage-restricted markers before ascribing their effects entirely to senolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results further validate the development of atherosclerosis in our model; however, as others have demonstrated16, senolytics do not appear to strongly alter the profile of known secreted proteins.”
From Single-cell and spatial transcriptomics map senescent vascular cells in arterial remodeling during atherosclerosis in mice (2025) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 1×
“Cell senescence is not a static cellular state, but a multistep process where cells undergo presenescence/quiescence, stable growth arrest, full senescence (chromatin changes associated with SASP) and late/deep senescence (phenotypic change/diversification).(46) The stage at which VSMCs express particular senescence m…”
BackgroundAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819 · cited 2×
“and herpes simplex virus thymidine kinase (TK) from a modified p16 promoter.(16,19) TK converts ganciclovir (GCV) into a toxic DNA chain terminator to selectively kill HSV-TK-expressing cells.”
BackgroundMethodProgrammed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Shankman, L. S., Gomez, D., Cherepanova, O. A., Salmon, M., Alencar, G. F., Haskins, R. M., Swiatlowska, P., Newman, A. A. C., Greene, E. S., Straub, A. C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3866 · Cited by 1,218
Senescent intimal foam cells are deleterious at all stages of atherosclerosis
Childs, B. G., Baker, D. J., Wijshake, T., Conover, C. A., Campisi, J., & van Deursen, J. M. (2016) · Science · doi:10.1126/science.aaf6659 · Cited by 1,195 · cited 6×
“This contrasts with a study where GCV treatment of Ldlr/p16-3MR mice reduced SAbGþ cells, atherosclerosis extent, expression of inflammatory cytokines (IL1a, TNFa, MCP-1, MMPs 3, 12 and 13), and p16.(5) This study concluded that GCV reduced atherosclerosis by removing senescent cells,(5) although detection and removal…”
BackgroundMethodResultInfluentialSenescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Our data are therefore consistent with studies that show that deleting p16þ cells can have neutral or detrimental effects in development, wound healing and a variety of disease states.(10,11,19,44,45) While cycles of ABT-263 do reduce atherosclerosis, ABT-263 had no effect on tissue markers of cell senescence, and als…”
ResultZhu, Y., Tchkonia, T., Fuhrmann‐Stroissnigg, H., Dai, H. M., Ling, Y. Y., Stout, M. B., Pirtskhalava, T., Giorgadze, N., Johnson, K. O., Giles, C. B., et al. (2016) · Aging Cell · doi:10.1111/acel.12445 · Cited by 1,148
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
Robbins, C. S., Hilgendorf, I., Weber, G. F., Theurl, I., Iwamoto, Y., Figueiredo, J.-L., Gorbatov, R., Sukhova, G. K., Gerhardt, L. M. S., Smyth, D., et al. (2013) · Nature Medicine · doi:10.1038/nm.3258 · Cited by 1,041 · cited 1×
“Macrophages in atherosclerosis arise from both migration from the bone marrow via peripheral blood and proliferation of resident macrophages.(20) In addition, previous studies demonstrated that foam cells expressing p16-3MR can be removed from atherosclerotic plaques by GCV.”
BackgroundWang (2012) · doi:10.1161/circresaha.111.261388 · Cited by 957 · cited 2×
“Senescent cells have been identified in atherosclerosis, particularly endothelial and vascular smooth muscle cells (VSMCs) (reviewed in ref.(1)).”
BackgroundShankman, L. S., Gomez, D., Cherepanova, O. A., Salmon, M., Alencar, G. F., Haskins, R. M., Swiatlowska, P., Newman, A. A. C., Greene, E. S., Straub, A. C., et al. (2016) · Nature Medicine · doi:10.1038/nm0216-217a · Cited by 764
Roos, C. M., Zhang, B., Palmer, A. K., Ogrodnik, M. B., Pirtskhalava, T., Thalji, N. M., Hagler, M., Jurk, D., Smith, L. A., Casaclang‐Verzosa, G., et al. (2016) · Aging Cell · doi:10.1111/acel.12458 · Cited by 738 · cited 2×
“30) Interestingly, while some senolytics such as ABT263 can remove senescent cells in tissues,(17,31) including in atherosclerotic plaques,(5) other agents, such as quercetin and dasatinib had no effect on plaque development or composition.(12) We therefore examined the ability of ABT-263, the most widely studied seno…”
BackgroundClarke, M. C. H., Figg, N., Maguire, J. J., Davenport, A. P., Goddard, M., Littlewood, T. D., & Bennett, M. R. (2006) · Nature Medicine · doi:10.1038/nm1459 · Cited by 646 · cited 1×
“However, atherosclerosis is associated with defective efferocytosis,(26) and both VSMC and macrophage apoptosis in atherosclerosis can be associated with inflammation, which can promote atherogenesis.(27,28) The number of TUNELþ apoptotic cells in aortic root plaques was increased in GCV-treated p16!p16 mice (which ex…”
BackgroundSelf-citationTabas, I. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000184783.04864.9f · Cited by 641 · cited 1×
“senescent cells could also be offset by pro-atherosclerotic effects of inducing apoptosis in VSMCs and macrophages in plaques.(1,13) We therefore examined the specificity and expression of traditional markers of cell senescence in human and mouse VSMCs in culture and in mouse atherosclerosis, and the effects of senoly…”
BackgroundMatthews, C., Gorenne, I., Scott, S., Figg, N., Kirkpatrick, P., Ritchie, A., Goddard, M., & Bennett, M. (2006) · Circulation Research · doi:10.1161/01.res.0000233315.38086.bc · Cited by 615 · cited 3×
“p16-expressing cells in human atherosclerotic plaque have been proposed to be of VSMC origin.(2) However, as VSMCs lose lineage markers when they de-differentiate and can gain ‘macrophage markers’(21) and”
BackgroundSelf-citationThe Clinical potential of Senolytic Drugs
Kirkland, J. L., Tchkonia, T., Zhu, Y., Niedernhofer, L. J., & Robbins, P. D. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14969 · Cited by 539
Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis
Schrijvers, D. M., De Meyer, G. R. Y., Kockx, M. M., Herman, A. G., & Martinet, W. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000166517.18801.a7 · Cited by 509
Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan
Grosse, L., Wagner, N., Emelyanov, A., Molina, C., Lacas-Gervais, S., Wagner, K.-D., & Bulavin, D. V. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.002 · Cited by 460 · cited 1×
“Our data are therefore consistent with studies that show that deleting p16þ cells can have neutral or detrimental effects in development, wound healing and a variety of disease states.(10,11,19,44,45) While cycles of ABT-263 do reduce atherosclerosis, ABT-263 had no effect on tissue markers of cell senescence, and als…”
ResultChappell, J., Harman, J. L., Narasimhan, V. M., Yu, H., Foote, K., Simons, B. D., Bennett, M. R., & Jørgensen, H. F. (2016) · Circulation Research · doi:10.1161/circresaha.116.309799 · Cited by 437 · cited 5×
“example in Myh11-Cre/Rosa26-Confetti mice; flow cytometric sorting of isolated confettiþ cells followed by single cell sequencing (scRNAseq) can then quantify mRNA expression specifically in VSMCs.(14,22) Normal healthy aortas of Myh11-Cre/Rosa26-Confetti mice showed cell clusters corresponding to VSMCs (Myh11þ), adve…”
BackgroundInfluentialSelf-citationHall, B. M., Balan, V., Gleiberman, A. S., Strom, E., Krasnov, P., Virtuoso, L. P., Rydkina, E., Vujcic, S., Balan, K., Gitlin, I. I., et al. (2017) · Aging · doi:10.18632/aging.101268 · Cited by 407
Hall, B. M., Balan, V., Gleiberman, A. S., Strom, E., Krasnov, P., Virtuoso, L. P., Rydkina, E., Vujcic, S., Balan, K., Gitlin, I., et al. (2016) · Aging · doi:10.18632/aging.100991 · Cited by 357 · cited 1×
“For example, we observe increased inflammation in GCV-treated p16!p16 mice, which may represent increased migration of p16þ macrophages, consistent with studies showing that senescent cells preferentially attract macrophages characterized by p16 gene expression and b-galactosidase activity.(39)”
ResultVascular Smooth Muscle Cell Senescence Promotes Atherosclerosis and Features of Plaque Vulnerability
Wang, J., Uryga, A. K., Reinhold, J., Figg, N., Baker, L., Finigan, A., Gray, K., Kumar, S., Clarke, M., & Bennett, M. (2015) · Circulation · doi:10.1161/circulationaha.115.016457 · Cited by 349
Self-citationDobnikar, L., Taylor, A. L., Chappell, J., Oldach, P., Harman, J. L., Oerton, E., Dzierzak, E., Bennett, M. R., Spivakov, M., & Jørgensen, H. F. (2018) · Nature Communications · doi:10.1038/s41467-018-06891-x · Cited by 302 · cited 6×
“example in Myh11-Cre/Rosa26-Confetti mice; flow cytometric sorting of isolated confettiþ cells followed by single cell sequencing (scRNAseq) can then quantify mRNA expression specifically in VSMCs.(14,22) Normal healthy aortas of Myh11-Cre/Rosa26-Confetti mice showed cell clusters corresponding to VSMCs (Myh11þ), adve…”
BackgroundMethodInfluentialSelf-citationGardner, S. E., Humphry, M., Bennett, M. R., & Clarke, M. C. H. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.305896 · Cited by 285 · cited 1×
“intensely SAbG-positive cells that also express p16, most SAbG-positive cells in human lesions are in the lesion core.(2,3) Similarly, the ‘canonical’”
BackgroundSelf-citationYu, E., Calvert, P. A., Mercer, J. R., Harrison, J., Baker, L., Figg, N. L., Kumar, S., Wang, J. C., Hurst, L. A., Obaid, D. R., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002271 · Cited by 283
Self-citationStoneman, V., Braganza, D., Figg, N., Mercer, J., Lang, R., Goddard, M., & Bennett, M. (2007) · Circulation Research · doi:10.1161/01.res.0000260802.75766.00 · Cited by 261 · cited 1×
“However, atherosclerosis is associated with defective efferocytosis,(26) and both VSMC and macrophage apoptosis in atherosclerosis can be associated with inflammation, which can promote atherogenesis.(27,28) The number of TUNELþ apoptotic cells in aortic root plaques was increased in GCV-treated p16!p16 mice (which ex…”
BackgroundSelf-citationA novel leukointegrin, αdβ2, binds preferentially to ICAM-3
Van der Vieren, M., Le Trong, H., Wood, C. L., Moore, P. F., John, T. S., Staunton, D. E., & Gallatin, W. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90058-6 · Cited by 255
Pan, J., Li, D., Xu, Y., Zhang, J., Wang, Y., Chen, M., Lin, S., Huang, L., Chung, E. J., Citrin, D. E., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.02.216 · Cited by 242 · cited 1×
“for 5 days followed by 3 weeks recovery, a regimen previously demonstrated to efficiently remove senescent cells in mice.(16,17) There was no difference in body weight, mean blood pressure, or serum lipids between control and ABT-263-treated mice (Supplementary material online, Table S2).”
MethodMacrophage Apoptosis Exerts Divergent Effects on Atherogenesis as a Function of Lesion Stage
Gautier, E. L., Huby, T., Witztum, J. L., Ouzilleau, B., Miller, E. R., Saint-Charles, F., Aucouturier, P., Chapman, M. J., & Lesnik, P. (2009) · Circulation · doi:10.1161/circulationaha.108.806158 · Cited by 235
Sentinel p16 INK4a+ cells in the basement membrane form a reparative niche in the lung
Reyes, N. S., Krasilnikov, M., Allen, N. C., Lee, J. Y., Hyams, B., Zhou, M., Ravishankar, S., Cassandras, M., Wang, C., Khan, I., et al. (2022) · Science · doi:10.1126/science.abf3326 · Cited by 181
Noureddine, H., Gary-Bobo, G., Alifano, M., Marcos, E., Saker, M., Vienney, N., Amsellem, V., Maitre, B., Chaouat, A., Chouaid, C., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.241299 · Cited by 173
Le, O. N. L., Rodier, F., Fontaine, F., Coppe, J., Campisi, J., DeGregori, J., Laverdière, C., Kokta, V., Haddad, E., & Beauséjour, C. M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00567.x · Cited by 168
Similarities and interplay between senescent cells and macrophages
Behmoaras, J., & Gil, J. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202010162 · Cited by 158 · cited 1×
“suggesting that p16 is another checkpoint in macrophage polarization, and that these markers do not necessarily indicate senescence.(40) These studies and our findings suggest significant limitations in using p16, p16 reporters, or p16-linked suicide genes and SAbG to identify and/or remove senescent cells in atherosc…”
ResultHamczyk, M. R., Villa-Bellosta, R., Gonzalo, P., Andrés-Manzano, M. J., Nogales, P., Bentzon, J. F., López-Otín, C., & Andrés, V. (2018) · Circulation · doi:10.1161/circulationaha.117.030856 · Cited by 153
Expression of Chr9p21 genes CDKN2B (p15), CDKN2A (p16, p14) and MTAP in human atherosclerotic plaque
Holdt, L. M., Sass, K., Gäbel, G., Bergert, H., Thiery, J., & Teupser, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.06.029 · Cited by 143
Cudejko, C., Wouters, K., Fuentes, L., Hannou, S. A., Paquet, C., Bantubungi, K., Bouchaert, E., Vanhoutte, J., Fleury, S., Remy, P., et al. (2011) · Blood · doi:10.1182/blood-2010-10-313106 · Cited by 125
Schiller, N. K., Kubo, N., Boisvert, W. A., & Curtiss, L. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1001.096724 · Cited by 103 · cited 1×
“Irradiation has variable effects on lesion size, with no change in brachiocephalic plaques,(42) increased lesions in aortic roots, or reduced lesions in descending aorta.(43) However, all our mice underwent comparable ir-”
BackgroundThorp, E., Li, Y., Bao, L., Yao, P. M., Kuriakose, G., Rong, J., Fisher, E. A., & Tabas, I. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.176495 · Cited by 96 · cited 1×
“However, macrophage survival is dependent upon expression of BCL2 family members, such that BCL2 knockout promotes macrophage apoptosis and necrotic core formation in plaques in mice.(32) ABT-263 also induced cell death of cultured bone marrow-derived macrophages above 1mM (Supplementary material online, Figure S11),…”
BackgroundMitochondrial DNA damage induces apoptosis in senescent cells
Laberge, R.-M., Adler, D., DeMaria, M., Mechtouf, N., Teachenor, R., Cardin, G. B., Desprez, P.-Y., Campisi, J., & Rodier, F. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.199 · Cited by 82
Calvert, P. A., Liew, T.-V., Gorenne, I., Clarke, M., Costopoulos, C., Obaid, D. R., O'Sullivan, M., Shapiro, L. M., McNab, D. C., Densem, C. G., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.229237 · Cited by 82 · cited 1×
“SASP markers such as matrix metalloproteinases (MMPs), tumour necrosis factor alpha (TNFa), interleukin (IL)6, and IL1a can be expressed by macrophages or other leucocytes, particularly after activation or DNA damage.(4) Studies using p16-directed cell suicide genes(5) or transgenic expression of telomere protein muta…”
BackgroundSelf-citationStojanović, S. D., Fuchs, M., Kunz, M., Xiao, K., Just, A., Pich, A., Bauersachs, J. K., Fiedler, J., Sedding, D., & Thum, T. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00520 · Cited by 53
Fuentes, L., Wouters, K., Hannou, S. A., Cudejko, C., Rigamonti, E., Mayi, T. H., Derudas, B., Pattou, F. N., Chinetti, G., Staels, B., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2324-0 · Cited by 51
Frescas, D., Hall, B. M., Strom, E., Virtuoso, L. P., Gupta, M., Gleiberman, A. S., Rydkina, E., Balan, V., Vujcic, S., Chernova, O. B., et al. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1339850 · Cited by 34
Irradiation abolishes smooth muscle investment into vascular lesions in specific vascular beds
Newman, A. A. C., Baylis, R. A., Hess, D. L., Griffith, S. D., Shankman, L. S., Cherepanova, O. A., & Owens, G. K. (2018) · JCI Insight · doi:10.1172/jci.insight.121017 · Cited by 31
Shearn, A. I. U., Deswaerte, V., Gautier, E. L., Saint-Charles, F., Pirault, J., Bouchareychas, L., Rucker, E. B., Beliard, S., Chapman, J., Jessup, W., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.239111 · Cited by 30
Sentinel p16 INK4a + cells in the basement membrane form a reparative niche in the lungPreprint
de Mochel, N. R., Cheong, K. N., Cassandras, M., Wang, C., Krasilnikov, M., Matatia, P. R., Molofsky, A. B., Campisi, J., & Peng, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.10.142893 · Cited by 6
Cited by
Mechanisms and consequences of endothelial cell senescence
Bloom, S. I., Islam, M. T., Lesniewski, L. A., & Donato, A. J. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00739-0 · Cited by 495
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 274
Han, Y., & Kim, S. Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00906-w · Cited by 201
New Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death
Bu, L.-L., Yuan, H., Xie, L., Guo, M.-H., Liao, D., & Zheng, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015160 · Cited by 145
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
Suda, M., Paul, K. H., Minamino, T., Miller, J. D., Lerman, A., Ellison-Hughes, G. M., Tchkonia, T., & Kirkland, J. L. (2023) · Cells · doi:10.3390/cells12091296 · Cited by 112
“Senolytics such as navitoclax [162,279], anti-GPNMB vaccination [222], digoxin [217,218,280], BPTES [220], and 17-DMAG (alvespimycin) [281], reduce atherosclerotic plaque formation and inflammation in atherosclerotic model mice.”
Background
Metadata
- Authors
- Garrido, A. M., Kaistha, A., Uryga, A. K., Oc, S., Foote, K., Shah, A., Finigan, A., Figg, N., Dobnikar, L., Jørgensen, H., & Bennett, M.
- Affiliations
- University of Cambridge (GB)
- Babraham Institute (GB)
- Corresponding author
- Bennett, Martin
- ORCID
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-06-17
- Volume
- 118
- Issue
- 7
- Pages
- 1713-1727
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC9215197
- OpenAlex
- W3171636888
- Cited by
- 83
- References
- 47
- Citations by year
- 2026: 12 · 2025: 21 · 2024: 20 · 2023: 23 · 2022: 6 · 2021: 1
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cardiovascular Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- British Heart Foundation (grants (RG71070, RG84554))
- BHF Centre for Research Excellence
- BHF Oxbridge Centre for Regenerative Medicine, and the National Institute of Health Research Cambridge Biomedical Research Centre
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- senolysis, atherosclerosis, cellular senescence, senolytics, navitoclax, p16, senescence-associated β-galactosidase, lamin B1, vascular smooth muscle cells, stress-induced premature senescence, atherosclerotic plaque, monocytes, platelets, inflammation, senescence markers, Sca-1
- MeSH terms
- Senotherapeutics, Animals, Cells, Cultured, Humans, Inflammation, Muscle, Smooth, Vascular, Biomarkers, Cellular Senescence, Myocytes, Smooth Muscle, Atherosclerosis, Mice, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.